Literature DB >> 23383392

Microglial chemotactic signaling factors in Alzheimer's disease.

James G McLarnon1.   

Abstract

The net migration of microglia induced by deposits of amyloid beta (Aβ) constitutes a chemotactic response of resident neuroimmune brain cells. This process serves to localize clusters of microglia nearby Aβ deposits preparatory to cellular activation and functional responses. Microglial responses to Aβ deposits localized in brain parenchyma and in blood vessels lead to acute and chronic neuroinflammation in Alzheimer's disease (AD) brain. This review summarizes studies on the prominent chemotactic factors MCP-1, MIP-1α and IL-8 and also includes recent work indicating VEGF and fractalkine as chemotactic agents. The possibility that microglial release of MCP-1 may play a role in mediating chemotactic responses of neural progenitor cells is also considered. The plethora of chemotactic factors and their cognate receptors suggests the utility in testing pharmacological modulation of chemotaxis for effects to inhibit chronic neuroinflammation and confer neuroprotection in AD animal models.

Entities:  

Keywords:  AD animal models.; Alzheimer’s disease (AD); Chemotactic factors; inflammatory responses; microglial chemotaxis

Year:  2012        PMID: 23383392      PMCID: PMC3560464     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  33 in total

1.  Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia.

Authors:  D G Walker; L F Lue; T G Beach
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

Review 2.  Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.

Authors:  L F Lue; D G Walker; J Rogers
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

Review 3.  Physiology of microglia.

Authors:  Helmut Kettenmann; Uwe-Karsten Hanisch; Mami Noda; Alexei Verkhratsky
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

Review 4.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 5.  Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease.

Authors:  J Rogers; L F Lue
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

6.  Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro.

Authors:  L F Lue; R Rydel; E F Brigham; L B Yang; H Hampel; G M Murphy; L Brachova; S D Yan; D G Walker; Y Shen; J Rogers
Journal:  Glia       Date:  2001-07       Impact factor: 7.452

7.  Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology.

Authors:  Jae K Ryu; Taesup Cho; Hyun B Choi; Yu Tian Wang; James G McLarnon
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

8.  Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Tae-Suk Kim; Hyun-Kook Lim; Ji Youl Lee; Dai-Jin Kim; Sanghi Park; Chul Lee; Chang-Uk Lee
Journal:  Neurosci Lett       Date:  2008-03-13       Impact factor: 3.046

9.  Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain.

Authors:  Jae K Ryu; Taesup Cho; Yu Tian Wang; James G McLarnon
Journal:  J Neuroinflammation       Date:  2009-12-23       Impact factor: 8.322

10.  Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases.

Authors:  Nicole M Desforges; Michaeline L Hebron; Norah K Algarzae; Irina Lonskaya; Charbel E-H Moussa
Journal:  Int J Alzheimers Dis       Date:  2012-08-05
View more
  14 in total

Review 1.  Microglial dysfunction in brain aging and Alzheimer's disease.

Authors:  Kira Irving Mosher; Tony Wyss-Coray
Journal:  Biochem Pharmacol       Date:  2014-01-18       Impact factor: 5.858

2.  Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism.

Authors:  Ning Dong; Bing Xu; Hong Shi
Journal:  Inflamm Res       Date:  2018-08-27       Impact factor: 4.575

Review 3.  Pulmonary hypertension: Pathophysiology beyond the lung.

Authors:  Aline C Oliveira; Elaine M Richards; Mohan K Raizada
Journal:  Pharmacol Res       Date:  2019-11-13       Impact factor: 7.658

Review 4.  Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases.

Authors:  Meghan C Gage; Thimmasettappa Thippeswamy
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

Review 5.  Advances in blood-based protein biomarkers for Alzheimer's disease.

Authors:  Lorraine Fuhrmann Clark; Thomas Kodadek
Journal:  Alzheimers Res Ther       Date:  2013-05-09       Impact factor: 6.982

6.  Migration-based selections of antibodies that convert bone marrow into trafficking microglia-like cells that reduce brain amyloid β.

Authors:  Kyung Ho Han; Britni M Arlian; Matthew S Macauley; James C Paulson; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

7.  Rhinacanthin C Alleviates Amyloid-β Fibrils' Toxicity on Neurons and Attenuates Neuroinflammation Triggered by LPS, Amyloid-β, and Interferon-γ in Glial Cells.

Authors:  Kai-An Chuang; Ming-Han Li; Ni-Hsuan Lin; Chih-Hsuan Chang; I-Huang Lu; I-Hong Pan; Tomoya Takahashi; Ming-Der Perng; Shu-Fang Wen
Journal:  Oxid Med Cell Longev       Date:  2017-10-18       Impact factor: 6.543

8.  Characterizing microglia activation: a spatial statistics approach to maximize information extraction.

Authors:  Benjamin M Davis; Manual Salinas-Navarro; M Francesca Cordeiro; Lieve Moons; Lies De Groef
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

9.  Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer's disease.

Authors:  Jae K Ryu; T Cho; Hyun B Choi; N Jantaratnotai; James G McLarnon
Journal:  J Neuroinflammation       Date:  2015-08-09       Impact factor: 8.322

10.  Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Authors:  R W Paterson; J W Bartlett; K Blennow; N C Fox; L M Shaw; J Q Trojanowski; H Zetterberg; J M Schott
Journal:  Transl Psychiatry       Date:  2014-07-29       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.